| Unlinking an lncRNA from its associated cis element VR Paralkar, CC Taborda, P Huang, Y Yao, AV Kossenkov, R Prasad, ... Molecular cell 62 (1), 104-110, 2016 | 251 | 2016 |
| Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development VR Paralkar, T Mishra, J Luan, Y Yao, AV Kossenkov, SM Anderson, ... Blood, The Journal of the American Society of Hematology 123 (12), 1927-1937, 2014 | 184 | 2014 |
| Long noncoding RNAs in biology and hematopoiesis VR Paralkar, MJ Weiss Blood, The Journal of the American Society of Hematology 121 (24), 4842-4846, 2013 | 76 | 2013 |
| Population characteristics and prognostic factors in metastatic non–small-cell lung cancer: a fox chase cancer center retrospective VR Paralkar, T Li, CJ Langer Clinical lung cancer 9 (2), 116-121, 2008 | 54 | 2008 |
| A new ‘Linc’between noncoding RNAs and blood development VR Paralkar, MJ Weiss Genes & development 25 (24), 2555-2558, 2011 | 53 | 2011 |
| Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia AH Matthews, AE Perl, SM Luger, AW Loren, SI Gill, DL Porter, ... Blood Advances 6 (13), 3997-4005, 2022 | 43 | 2022 |
| Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas VR Paralkar, SD Nasta, K Morrissey, J Smith, P Vassilev, ME Martin, ... Bone marrow transplantation 47 (7), 940-945, 2012 | 40 | 2012 |
| Regulation of gene expression by miR-144/451 during mouse erythropoiesis P Xu, LE Palmer, C Lechauve, G Zhao, Y Yao, J Luan, A Vourekas, H Tan, ... Blood, The Journal of the American Society of Hematology 133 (23), 2518-2528, 2019 | 38 | 2019 |
| HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis K Lv, C Gong, C Antony, X Han, JG Ren, R Donaghy, Y Cheng, ... Cell Stem Cell 28 (7), 1275-1290. e9, 2021 | 33 | 2021 |
| A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia T Harada, Y Heshmati, J Kalfon, MW Perez, JX Ferrucio, J Ewers, ... Genes & development 36 (5-6), 368-389, 2022 | 16 | 2022 |
| Control of ribosomal RNA synthesis by hematopoietic transcription factors C Antony, SS George, J Blum, P Somers, CL Thorsheim, DJ Wu-Corts, ... Molecular cell 82 (20), 3826-3839. e9, 2022 | 12 | 2022 |
| Transcriptional plasticity drives leukemia immune escape K Eagle, T Harada, J Kalfon, MW Perez, Y Heshmati, J Ewers, JV Koren, ... Blood Cancer Discovery 3 (5), 394-409, 2022 | 10 | 2022 |
| Nonspecific inhibition of erythropoiesis by short hairpin RNAs EA Traxler, CS Thom, Y Yao, V Paralkar, MJ Weiss Blood, The Journal of the American Society of Hematology 131 (24), 2733-2736, 2018 | 10 | 2018 |
| Severe eosinophilia as a manifestation of acute graft-versus-host disease VR Paralkar, A Goradia, SM Luger, AW Loren Oncology 75 (3-4), 134-136, 2008 | 9 | 2008 |
| Real world survival outcomes of CPX-351 versus venetoclax and azacitadine for initial therapy in adult acute myeloid leukemia A Matthews, AE Perl, SM Luger, DV Babushok, NV Frey, S Gill, ... Blood 138, 795, 2021 | 7 | 2021 |
| A pilot trial of quantitative Epstein–Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein–Barr virus polymerase … DE Tsai, MR Luskin, BE Kremer, AK Chung, S Arnoldi, VR Paralkar, ... Leukemia & Lymphoma 56 (5), 1530-1532, 2015 | 7 | 2015 |
| Worlds apart—tuberculosis in India and the United States V Paralkar New England Journal of Medicine 358 (11), 1092-1095, 2008 | 6 | 2008 |
| YODEL: peak calling software for HITS-CLIP data LE Palmer, MJ Weiss, VR Paralkar F1000Research 6, 1138, 2017 | 5 | 2017 |
| Anticoagulation: An Update for primary care VR Paralkar, RN Rubin Consultant 51 (10), 2011 | 5 | 2011 |
| Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia AH Matthews, AE Perl, SM Luger, SI Gill, C Lai, DL Porter, S Skuli, ... American Journal of Hematology 98 (8), 1254-1264, 2023 | 4 | 2023 |
